MPI Research competitors

MPI Research Competitors include Cellular Biomedicine Group, Cascadian Therapeutics, GlycoMimetics and OncoMed Pharmaceuticals.
Add company...
MPI Research
MPI Research
MPI Research provides preclinical services to agricultural, environmental, biopharmaceutical, medical device, animal health, and chemical industries.
Cellular Biomedicine Group
Cellular Biomedicine Group
Cellular Biomedicine Group is a clinical-stage biopharmaceutical firm engaged in the development of effective immunotherapies for cancer and stem cell therapies for degenerative diseases.
Cascadian Therapeutics
Cascadian Therapeutics
Cascadian Therapeutics, Inc., formerly Oncothyreon Inc., is a clinical-stage biopharmaceutical company.
GlycoMimetics
GlycoMimetics
GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers.
OncoMed Pharmaceuticals
OncoMed Pharmaceuticals
OncoMed Pharmaceuticals is a biotechnology company developing novel therapeutics for the treatment of cancer.
Founding Date
Founding Date
1995
Founding Date
2009
Founding Date
2007
Founding Date
2003
Founding Date
2004
Type
Type
Subsidiary
Type
Public
Type
Subsidiary
Type
Public
Type
Public
Tags
Locations
Locations
Mattawan, US HQ
Locations
Cupertino, US HQ
Beijing, CN
Shanghai, CN
Hong Kong , HK
Locations
Seattle, US HQ
Locations
Rockville, US HQ
Locations
Redwood City, US HQ
Employees
Employees
N/A
Employees
12515% increase
Employees
N/A
Employees
405% decrease
Employees
122
Valuation ($)
Valuation ($)
N/A
Valuation ($)
369.8 m
Valuation ($)
N/A
Valuation ($)
465.5 m
Valuation ($)
33.6 m
Twitter followers
Twitter followers
476
Twitter followers
154
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$336.8k (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$38.2m (FY, 2017)
Net income
Net income
N/A
Net income
($25.5m) (FY, 2017)
Net income
($56.9m) (FY, 2017)
Net income
N/A
Net income
($39.1m) (FY, 2017)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 101.8m
Total funding raised
$ 210.2m
For sources of this data, please see the company profileDownload Excel

View company profiles

Cellular Biomedicine Group
HQ
Cupertino, US
Employees
125↑ 15% increase

Cellular Biomedicine Group is a clinical-stage biopharmaceutical firm engaged in the development of effective immunotherapies for cancer and stem cell therapies for degenerative diseases.

View company
Cascadian Therapeutics
HQ
Seattle, US

Cascadian Therapeutics, Inc., formerly Oncothyreon Inc., is a clinical-stage biopharmaceutical company.

View company
GlycoMimetics
HQ
Rockville, US
Employees
40↓ 5% decrease

GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers.

View company
OncoMed Pharmaceuticals
HQ
Redwood City, US
Employees
122

OncoMed Pharmaceuticals is a biotechnology company developing novel therapeutics for the treatment of cancer.

View company